
Nexsen
Short position
Nexsen (ASX:NXN) has 0.02% of its shares on issue reported as short positions as of 6 July 2026, or about 21,838 shares. NXN is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4Nexsen (NXN) Short Interest
Nexsen (ASX:NXN) had 0.02% of shares reported as short positions as of 6 July 2026, representing 21,838 shares. Nexsen operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Short interest
History & FAQ →Weekly context: The 10 most shorted ASX stocks — Week 41, 2026.
Strategy fit
How each stock picker strategy reads NXN today
- Zanger BreakoutNot a candidate
- CAN SLIMNot a candidate
- Minervini Trend TemplateWatchScore 6rank 1731 of 1764
- Crowded-Short BreakoutNot a candidate
- Quality compoundersWatchScore 24rank 617 of 1688
Prices to 9 Oct 2026 · Mechanical readings of published rules, not recommendations · Not financial adviceFull strategy readings →
NXN fundamentals
In the year to 30 Jun 2026, Nexsen (ASX:NXN) recorded revenue of A$1.1M and a net loss after tax of A$6.6M. A year earlier it recorded revenue of A$931.6K and a net loss after tax of A$5.0M. Year-on-year growth: revenue +16.9% (FY). Net margin −601.8% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 29 Sep 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
Latest NXN news
All news- Notice of AGM and Meeting Materials
asx · 6 Oct 2026
- Professor Shekhar Kumta appointed Executive Director
asx · 30 Sept 2026
- Nexsen Enters into Molecular GBS Diagnostic Joint Venture with FlashDx Shenzhen
smallcaps · 25 Sept 2026
About
Company information is being updated. Check back soon.
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss NXN
Start a research thread or post the first pulse update